Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the year ending March 31, 2023. For the year ending March 31, 2023, the company expects to report net sales of ¥9,000 million, operating profit of ¥1,200 million, and profit of ¥840 million or ¥29.24 per share.